Rapid Changes in D1 and D2 Dopamine Receptor Binding in Striatal Subregions after a Single Dose of Phencyclidine
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: In humans, a single exposure to phencyclidine (PCP) can induce a schizophrenia-like psychosis which can persist for up to two weeks. In rats, an acute dose of PCP increases dopaminergic activity and causes changes in dopamine related behaviours some of which are sexually dimorphic. To better understand the effects of PCP on dopamine receptor adaptations in the short term we examined dopamine D1-like receptors (D1R) and D2-like receptors (D2R) in the mesolimbic and nigrostriatal dopamine pathways, 4 hours after exposure to PCP in female rats. Methods: Animals received a single dose of 40 mg/kg PCP and were sacrificed 4 hours later. In vitro autoradiography was carried out using [^3H] SCH 23390 and [^3H] raclopride that target D1R and D2R respectively, in cryostat brain sections. Results: Two way analysis of variance (ANOVA), revealed an overall effect of PCP treatment (F [1,63]=9.065; p=0.004) on D1R binding with an 18% decrease (p＜0.01) in binding in the medial caudate putamen. PCP treatment also had an overall effect on D2R binding (F [1,47]=5.450; p=0.024) and a trend for an increase in D2R binding across all the brain regions examined. Conclusion: These results suggest opposing D1R and D2R adaptations in striatal subregions of female rats following acute exposure to PCP that may occur through indirect mechanisms.
Abstract
Objective: In humans, a single exposure to phencyclidine (PCP) can induce a schizophrenia-like psychosis which can persist for up to two weeks. In rats, an acute dose of PCP increases dopaminergic activity and causes changes in dopamine related behaviours some of which are sexually dimorphic. To better understand the effects of PCP on dopamine receptor adaptations in the short term we examined dopamine D1-like receptors (D1R) and D2-like receptors (D2R) in the mesolimbic and nigrostriatal dopamine pathways, 4 hours after exposure to PCP in female rats. Methods: Animals received a single dose of 40 mg/kg PCP and were sacrificed 4 hours later. In vitro autoradiography was carried out using [^3H] SCH 23390 and [^3H] raclopride that target D1R and D2R respectively, in cryostat brain sections. Results: Two way analysis of variance (ANOVA), revealed an overall effect of PCP treatment (F [1,63]=9.065; p=0.004) on D1R binding with an 18% decrease (p＜0.01) in binding in the medial caudate putamen. PCP treatment also had an overall effect on D2R binding (F [1,47]=5.450; p=0.024) and a trend for an increase in D2R binding across all the brain regions examined. Conclusion: These results suggest opposing D1R and D2R adaptations in striatal subregions of female rats following acute exposure to PCP that may occur through indirect mechanisms.
참고문헌 (37)
- Javitt DC, "Recent advances in the phencyclidine model of schizophrenia", Am J Psychiatry, 148, pp.1301~1308 (1991)
- Steinpreis RE, "The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis", Behav Brain Res, 74, pp.45~55 (1996)
- Creese I, "Receptor adaptations to centrally acting drugs", Annu Rev Pharmacol Toxicol, 21, pp.357~391 (1981)
- Dawson TM, "Wamsley JK. D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis", J Neurosci, 6, pp.2352~2365 (1986)
- Geyer MA, "Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review", Psychopharmacology (Berl), 156, pp.117~154 (2001)
- Haggerty GC, "The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period", Toxicol Appl Pharmacol, 75, pp.444~453 (1984)
- Hertel P, "Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat", Behav Brain Res, 72, pp.103~114 (1995)
- Jentsch JD, "The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia", Neuropsychopharmacology, 20, pp.201~225 (1999)
- Steinpreis RE, "The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study", Brain Res, 612, pp.263~270 (1993)
- Tsutsumi T, "Involvement of dopamine D1 receptors in phencyclidine-induced behavioral stimulation in rats", Clin Neuropharmacol, 18, pp.64~71 (1995)
- Frederick DL, "Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery", Pharmacol Biochem Behav, 52, pp.789~797 (1995)
- Jentsch JD, "Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966", JNeurosci, 17, pp.1769~1775 (1997)
- Mele A, "The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs", Psychopharmacology (Berl), 135, pp.107~118 (1998)
- Dunn MJ, "SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance", Psychopharmacology (Berl), 190, pp.403~414 (2007)
- Giannini AJ, "Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis", J Clin Pharmacol, 24, pp.202~204 (1984)
- Ogren SO, "Phencyclidine and dizocilpineinduced hyperlocomotion are differentially mediated", Neuropsychopharmacology, 11, pp.167~177 (1994)
- Tomić M, "Acute amphetamine and", or phencyclidine effects on the dopamine receptor specific binding in the rat brain, 1997, pp.7, 295~301
- Nabeshima T, "Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats", Eur J Pharmacol, 97, pp.217~227 (1984)
- Shelnutt SR, "Sexual dimorphism in phencyclidine in vitro metabolism and pharmacokinetics in rats", J Pharmacol Exp Ther, 290, pp.1292~1298 (1999)
- Wessinger WD, "Sexual dimorphic effects of chronic phencyclidine in rats", Eur J Pharmacol, 227, pp.107~112 (1995)
- Lewis DA, "Catching up on schizophrenia:natural history and neurobiology", Neuron, 28, pp.325~334 (2000)
- Paxinos G, "The Rat Brain in Stereotaxic Coordinates. 6th ed" (1997), Academic Press
- Joyce JN, "Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia", Synapse, 2, pp.546~557 (1988)
- Köhler C, "Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain", Biochem Pharmacol, 34, pp.2251~2259 (1985)
- Scarr E, "Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia", Mol Psychiatry, 14, pp.1017~1023 (2009)
- Radja F, "Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis", Neuroscience, 57, pp.635~648 (1993)
- MacRae PG, "Reaction time and nigrostriatal dopamine function: the effects of age and practice", Brain Res, 451, pp.139~146 (1998)
- Minuzzi L, "Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo", Synapse, 59, pp.211~219 (2006)
- Dean B, "Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic", mutant mice, 2008, pp.99, 341~349
- Ushijima I, "Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats", Pharmacol Biochem Behav, 52, pp.737~741 (1995)
- Viggiano D, "Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder", Neurosci Biobehav Rev, 27, pp.623~637 (2003)
- Guo N, "Abi-Dargham A. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia", Neuropsychopharmacology, 28, pp.1703~1711 (2003)
- SCH 23390 induced by MK-801 in the mouse striatum, "Neuropharmacology", 1993, 341~348
- Schiffer WK, "Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine", Neuropsychopharmacology, 28, pp.2192~2198 (2003)
- Zavitsanou K, "Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia", J Chem Neuroanat, 36, pp.71~76 (2008)
- Takahata R, "Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area", J Neurochem, 75, pp.1775~1778 (2000)
- Howes OD, "The dopamine hypothesis of schizophrenia: version III-the final common pathway", Schizophr Bull, 35, pp.549~562 (2009)